Novel thienopyrimidines of formula (I), in which R1, R2, and X have the meanings indicated in claim 1, are TGF-beta receptor kinase inhibitors and can be used for the treatment of tumors, among other things.
申请公布号
CA2720878(A1)
申请公布日期
2009.10.15
申请号
CA20092720878
申请日期
2009.03.23
申请人
MERCK PATENT GMBH
发明人
HOELZEMANN, GUENTER;GREINER, HARTMUT;AMENDT, CHRISTIANE;ZENKE, FRANK
